目的：探讨复明片治疗轻、中度非增殖性糖尿病性视网膜病变的临床效果。方法：选取轻、中度非增殖性糖尿病视网膜病变患者120例，以随机数字表法分为2组各60例。在常规控制血糖的基础上，观察组患者口服复明片，对照组口服复方丹参片。观察治疗3个月后2组患者的视力，采用光学相干断层扫描技术观察治疗3个月后2组患者的黄斑厚度。结果：观察组患者视力改善的总有效率为80.00％（48／60），明显高于对照组的58.33％（35／60），差异有统计学意义（P＜0.05）。治疗前，2组患者黄斑厚度的差异无统计学意义（P＞0.05）；治疗3个月后，观察组患者的黄斑厚度为（196.62±25.03）μm，较本组治疗前的（233.62±18.41）μm及对照组治疗后的（229.18±36.52）μm均明显减少，差异均有统计学意义（P＜0.05）。结论：复明片治疗轻、中度非增殖性糖尿病视网膜病变安全、有效。%OBJECTIVE:To investigate the clinic efficacy of Fuming tablet in treatment of mild、moderate non-proliferative diabetic retinopathy .METHODS: 120 patients with mild、moderatenon-proliferative diabetic retinopathy were randomly divided into two groups by random number table , 60 cases in each group .Based on conventional therapy of DM, the observation group took Fuming tablet orally;the control group took compound Salvia tablet orally . The visual acuity was observed after the treatment of 3 month, and macular thickness was measured by OCT . RESULTS:The effective rate of improved visual acuity was 80.00%( 48/60 ) in treatment group , which was higher than that in the control group [ 58.33%( 35/60 ) ] , with significant difference ( P0.05 ) .After the treatment of 3 month, macular thickness was (196.62 ±25.03)μm in treatment group which significantly decreased compared with before-treatment [ ( 233.62 ±18.41 )μm ] and control group after-treatment [ ( 229.18 ±36.52 ) μm ] . The differences were statistically significant ( P<0.05 ) .CONCLUSIONS:Fuming tablet is effective and safe in treatment of mild、moderate non-proliferative diabetic retinopathy.
展开▼
